BRNS Barinthus Biotherapeutics
- 1.500
- 0.0000.00%
Barinthus Biotherapeutics News
4: Statement of changes in beneficial ownership of securities-Officer Hooftman Leon
3: Initial statement of beneficial ownership of securities-Officer Hooftman Leon
8-K: Current report
8-K: Current report
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wright Robin
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director DAWES KAREN A
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Scheeren Joseph
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hammacher Alex
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morgon Pierre A.
Barinthus Biotherapeutics | 8-K/A: Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
Barinthus Biotherapeutics | 10-Q: Quarterly report
Barinthus Biotherapeutics | 8-K: Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
Barinthus Biotherapeutics | 8-K: Current report
Barinthus Biotherapeutics | ARS: Annual Report to Security Holders
Barinthus Biotherapeutics | DEFA14A: Others
Barinthus Biotherapeutics | DEF 14A: Definitive information statements
Barinthus Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Barinthus Biotherapeutics | 10-K: Annual report
Analysis
Price Target
No Data
